IgA nephropathy, an immune assault on the kidneys, is often missed. New treatments mean that spotting it sooner might save ...

Confirmed response rates in expansion cohorts of 32% at 10 mg/kg Q3W dose and 20% at 8.6 mg/kg Q3W -- Estimated progression free survival of ...

Prophylactic nasal budesonide spray reduces nasal inflammation and modulates epigenetic age acceleration (EAA) in patients with allergic rhinitis before and after repeated acute exposures to an ...

IgA nephropathy (IgAN), or Berger’s disease, is a kidney condition that occurs when abnormal immunoglobulin A (IgA) antibodies trigger inflammation in the kidneys. Until recently, treatment for IgAN ...

As new trial findings show significant reductions in paediatric asthma attacks from a budesonide-formoterol 2-in-1 reliever therapy, Professor Andy Bush speaks to Saša Janković about the system ...

More common side effects of Tarpeyo (budesonide) include swelling of your hands, legs, ankles, or feet, acne, headache, high blood pressure, and muscle spasms. Tarpeyo can cause side effects that ...

A major new study has provided evidence that treatment for childhood asthma could be significantly improved by replacing traditional salbutamol relievers with budesonide–formoterol. This randomised ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomised controlled trial to investigate the use of a ...

Mild asthma could be better treated with the recent approval of the combination of albuterol/budesonide. The recent approval of albuterol/budesonide could change the way that mild asthma is treated in ...

Severe exacerbation occurred in 5.1% of patients taking albuterol/budesonide compared with 9.1% of patients taking albuterol alone in the on-treatment efficacy population. Albuterol/budesonide ...